CIITA and hepatocellular carcinoma: For example, Elise (Ramia et al., 2019) found that, in HCC cell lines, human leukocyte antigen (HLA) class II expression shortage was caused by the lack of the HLA class II transactivator (i.e., CIITA), and interferon-gamma treatment could not improve the situation.